The trajectory of Viagra, initially marketed by copyright, presents a fascinating case study for stakeholders considering the drug arena . Although its groundbreaking success and impact of vast in revenue , the patent lapse has opened the floodgates for competing medications, greatly eroding profit opportunities. This change raises doubts about the